These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38004450)

  • 1. A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated
    Vintila BI; Arseniu AM; Morgovan C; Butuca A; Sava M; Bîrluțiu V; Rus LL; Ghibu S; Bereanu AS; Roxana Codru I; Gligor FG
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and
    Vintila BI; Arseniu AM; Morgovan C; Butuca A; Bîrluțiu V; Dobrea CM; Rus LL; Ghibu S; Bereanu AS; Arseniu R; Roxana Codru I; Sava M; Gabriela Gligor F
    Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391530
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database.
    Vintila BI; Arseniu AM; Butuca A; Sava M; Bîrluțiu V; Rus LL; Axente DD; Morgovan C; Gligor FG
    Antibiotics (Basel); 2023 May; 12(5):. PubMed ID: 37237821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data.
    Liu Y; Dai M; Zhang K; Zhang L; Lin B; Chen K; Wang H; Gu Z; Yu Y; Wang Y
    Int J Antimicrob Agents; 2024 Jul; 64(4):107288. PubMed ID: 39089342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration.
    Alammari KM; Thabit AK
    Gut Pathog; 2021 Feb; 13(1):10. PubMed ID: 33593421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics Associated With Clostridium difficile Infection.
    Rafey A; Jahan S; Farooq U; Akhtar F; Irshad M; Nizamuddin S; Parveen A
    Cureus; 2023 May; 15(5):e39029. PubMed ID: 37323360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of
    Li D; Song Y; Bai Z; Xi X; Liu F; Zhang Y; Qin C; Du D; Du Q; Liu S
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
    Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Acute Kidney Injury and Clostridioides difficile Infection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin.
    Lee JD; Heintz BH; Mosher HJ; Livorsi DJ; Egge JA; Lund BC
    Clin Infect Dis; 2021 Oct; 73(7):e1579-e1586. PubMed ID: 33382398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
    Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
    BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epidemiological surveillance study (2021-2022): detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China.
    Cui Y; Zhang C; Jia Q; Gong X; Tan Y; Hua X; Jian W; Yang S; Hayer K; Raja Idris RK; Zhang Y; Wu Y; Tu Z
    BMC Infect Dis; 2023 Oct; 23(1):703. PubMed ID: 37858038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of antibiotic consumption targets for the management of
    Aldeyab MA; Bond SE; Gould I; Lee-Milner J; Spencer-Jones JJ; Guleri A; Sadeq A; Jirjees F; Lattyak WJ
    Expert Rev Anti Infect Ther; 2023; 21(10):1125-1134. PubMed ID: 37755320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic Guidelines for Critically Ill Patients in Nigeria.
    Oladele RO; Ettu AO; Medugu N; Habib A; Egbagbe E; Osinaike T; Makanjuola OB; Ogunbosi B; Irowa OO; Ejembi J; Uwaezuoke NS; Adeleke G; Mutiu B; Ogunsola F; Rotimi V
    West Afr J Med; 2023 Sep; 40(9):962-972. PubMed ID: 37768104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omadacycline and
    Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
    Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
    Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
    J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Boyanova L; Dimitrov G; Gergova R; Hadzhiyski P; Markovska R
    Expert Rev Clin Pharmacol; 2023; 16(10):925-938. PubMed ID: 37642560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.